|
HHS Adolescent Health Working Group
|
Committee, Work group, Advisory group, or Task Force
|
ACF, AHRQ, CDC, CMS, FDA, HRSA, OS, SAMHSA
|
NIDA, NIAAA, NICHD, NIMH
|
Interagency working group established in January 2010 within the Office of the Assistant Secretary for Health as a forum for HHS agencies to share updates on adolescent health activities and address cross-cutting issues.
|
|
HHS Adult and Adolescent HIV Treatment Guidelines Panel
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, HRSA
|
NICHD
|
The purpose of this committee is to support and improve the HIV Treatment Guidelines.
|
|
HHS Advisory Committee on Blood & Tissue Safety & Availability (ACBTSA)
|
Committee, Work group, Advisory group, or Task Force
|
CDC, CMS, FDA, HRSA, OS
|
NHLBI, CC
|
This federal advisory committee advises the Secretary of the Department of Health and Human Services and the Assistant Secretary for Health on a number of issues related to blood (and tissue) safety including, public health parameters related to the safety and availability of blood and blood products; broad public health, ethical, and legal issues related to transfusion and transplantation safety; and the effect of various economic factors on blood (and tissue) safety and availability (and infectious disease concerns for organ transplantation). The ACBTSA is a Federal Advisory Committee (i.e., a FACA) seated with industry representatives, physicians/scientists, consumer advocates, and federal ex-officio members from the HHS Agencies, the Department of Defense, and the Department of Veteran''s Affairs.
|
|
HHS Arctic Working Group
|
Committee, Work group, Advisory group, or Task Force
|
ACF, AHRQ, CDC, CMS, HRSA, SAMHSA
|
NIMH, NIDA, NIEHS, NIGMS, NIMHD
|
The HHS Arctic Working Group was organized in March 2015 by the Office of Global Affairs, Office of the HHS Secretary. The purpose of the Working Group is to (1) ensure coordination of deliverables to the Arctic Executive Steering Committee (AESC), which was established by Executive Order and held its first meeting in February, 2015; (2) provide an opportunity for cross-agency learning and communication regarding activities and projects in Arctic regions; and (3) facilitate future interagency collaborations.
|
|
HHS ASPR Obstetric-Pediatric and Chemical Integrated Program Teams (IPT)
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, OS
|
NICHD
|
This workgroup is a Public Health Energy Enterprise. The IPT working group provides an end-to-end vision of medical countermeasures needed for a particular threat type (e.g., anthrax, rad/nuc, etc.). The scope of their work includes setting requirements for the stockpiling of Medical Countermeasures (MCMs), MCM delivery, and dispensing and monitoring MCM development. The IPTs also advise the Enterprise Executive Committee as to threat- or capability-specific MCM priorities for improving preparedness, to inform leadership consideration of cross-threat prioritizations and strategic goal setting.
|
|
HHS Behavioral Health Coordinating Committee (BHCC) Subcommittee on Behavioral Health Quality Measures
|
Committee, Work group, Advisory group, or Task Force
|
CMS, SAMHSA
|
NIDA
|
A subcommittee of the HHS Behavioral Health Coordinating Committee is a coordinating body within the U.S. Department of Health and Human Services (HHS) that identifies and facilitates collaborative, action-oriented approaches to addressing the HHS behavioral health agenda. This subcommittee addresses behavioral health quality measures.
|
|
HHS Behavioral Health Coordinating Committee (BHCC) Subcommittee on Communications
|
Committee, Work group, Advisory group, or Task Force
|
ACL, OS
|
NIDA, NIMH
|
A subcommittee of the HHS Behavioral Health Coordinating Committee is a coordinating body within the U.S. Department of Health and Human Services (HHS) that identifies and facilitates collaborative, action-oriented approaches to addressing the HHS behavioral health agenda. This subcommittee of communication professionals collaborates on inter-departmental behavioral health initiatives and promotional efforts.
|
|
HHS Behavioral Health Coordinating Committee (BHCC) Subcommittee on Prescription Drug Abuse
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA
|
NIDA
|
A subcommittee of the HHS Behavioral Health Coordinating Committee is a coordinating body within the U.S. Department of Health and Human Services (HHS) that identifies and facilitates collaborative, action-oriented approaches to addressing the HHS behavioral health agenda. The National Institute of Drug Abuse (NIDA) Serves as Co-Chair with FDA on this inter-agency subcommittee addressing prescription drug abuse.
|
|
HHS Biannual Dual Use Research of Concern (DURC) Inventory
|
Resource Development
|
CDC, FDA, OS
|
OD/OSP, CC, FIC, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/DPCPSI
|
Development of the HHS Biannual Dual Use Research of Concern (DURC) inventory reports, as required by the USG Policy for Oversight of Dual Use Research of Concern.
|
|
HHS Biomedical Advanced Research and Development Authority (BARDA) Armed Forces-Radiobiology Research Institute (AFRRI) Good Laboratory Practices (GLP) Integrated Project Team
|
Committee, Work group, Advisory group, or Task Force
|
OS
|
NIAID
|
The National Institute of Allergy and Infectious Diseases (NIAID) participates on the HHS BARDA Armed Forces Radiobiology Research Institute (AFRRI) Good Laboratory Practices (GLP) Integrated Project Team to collaborate and provide subject matter expertise, advice, and guidance on establishing a quality assurance program at AFRRI for GLP compliance.
|